Vitamin D3 administration to MS patients leads to increased serum levels of latency activated peptide (LAP) of TGF-beta
(Q52958869)
scientific article published on 21 January 2015
scientific article published on 21 January 2015
Language:
Current Data About
Vitamin D3 administration to MS patients leads to increased serum levels of latency activated peptide (LAP) of TGF-beta
other details
| description | scientific article published on 21 January 2015 |
External Links
| (P356) |
10.1016/J.JNEUROIM.2015.01.005
|
| (P698) |
25773149
|